Read + Share
Gorelik Y, Ghersin I, Lujan R, Shlon D, et al. GLP-1 analog use is associated with improved disease course in inflammatory bowel
disease: a report from the Epi-IIRN. J Crohns Colitis 2024 Oct 23:jjae160. doi: 10.1093.
PMID: 39441993
|
 |
|
Gorelik Y, Ghersin I, Lujan R, Shlon D, et al. GLP-1 analog use is associated with improved disease course in inflammatory bowel
disease: a report from the Epi-IIRN. J Crohns Colitis 2024 Oct 23:jjae160. doi: 10.1093.
PMID: 39441993
|
|
|
|